amlodipine 2.5 MG Oral Tablet [Norvasc]

Verify with CMS →

amlodipine

RxCUI: 212542

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.
0%
Plan Coverage
2
Plans Covering
T1
Avg Tier
0%
Prior Auth Required

What the CMS Formulary Data Shows for amlodipine 2.5 MG Oral Tablet [Norvasc]

Per the CMS 2026 Part D formulary file, amlodipine 2.5 MG Oral Tablet [Norvasc] (RxNorm concept RXCUI 212542, generic name amlodipine) appears on 1 distinct formulary file spanning 2 Medicare Part D plan offerings - 0% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 1, with a cross-plan average of Tier 1.

Real-world access to amlodipine 2.5 MG Oral Tablet [Norvasc] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 11,575,402 Part D beneficiaries filled amlodipine 2.5 MG Oral Tablet [Norvasc] in 2023, with total plan-and-beneficiary spending of $407,233,375 and an average per-beneficiary annual cost of $35.18. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry amlodipine 2.5 MG Oral Tablet [Norvasc] today.

Coverage Details

Formularies covering
1
Plans covering
2
Coverage rate
0%
Tier range
Tier 1, Preferred Generic
Average tier
Tier 1, Preferred Generic

Restrictions

Prior authorization required
0% of formularies
Step therapy required
0% of formularies
Quantity limits
0% of formularies

2023 Medicare Spending

Beneficiaries
11,575,402
Total spending
$407,233,375
Avg per beneficiary
$35.18

Tier Distribution Across Plans

2 plans
Tier 1, Preferred Generic

Medicare Advantage Plans (MA-PD) Covering amlodipine 2.5 MG Oral Tablet [Norvasc]

2 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
Hamaspik Medicare Choice (HMO D-SNP) HAMASPIK, INC. T1 No $0 NY
Hamaspik Medicare Select (HMO D-SNP) HAMASPIK, INC. T1 No $34.50 NY

Frequently Asked Questions

Is amlodipine 2.5 MG Oral Tablet [Norvasc] covered by Medicare Part D?

Yes, amlodipine 2.5 MG Oral Tablet [Norvasc] is covered by 2 Medicare Part D plans (0% of all Part D formularies).

What tier is amlodipine 2.5 MG Oral Tablet [Norvasc] on Medicare Part D plans?

amlodipine 2.5 MG Oral Tablet [Norvasc] averages Tier 1 across Part D plans, ranging from Tier 1 to Tier 1.

Does amlodipine 2.5 MG Oral Tablet [Norvasc] require prior authorization?

0% of Part D formularies require prior authorization for amlodipine 2.5 MG Oral Tablet [Norvasc]. Step therapy: 0%. Quantity limits: 0%.

How much does Medicare spend on amlodipine 2.5 MG Oral Tablet [Norvasc]?

In 2023, total Medicare Part D spending on amlodipine 2.5 MG Oral Tablet [Norvasc] was $407,233,375, covering 11,575,402 beneficiaries. The average spend per beneficiary was $35.18.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare Editorial